Form D · Pharmaceuticals
XEME Biopharma, Inc.
Lombard, IL · CIK 0001696915
Offering snapshot reported Apr 4, 2017 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-284014
Source: Form D, filed Apr 4, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sunil S. Metkar | Executive |
| Dorel Nasui | Director |
| Mircea C. Popescu | Director, Executive |
| Richard J. Robb | Executive |
| Anthony Tate | Executive |
| Marius Teodorescu | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1120 N. Dupage Avenue
Lombard, IL, 60148
Lombard, IL, 60148